When stroke drug developer Argenica Therapeutics (ASX:AGN) revisited the results of its recent phase II trial, it turned to a ...

December 22, 2025—iVascular announced the initiation of the 4-NiVO clinical study, which is evaluating the efficacy and safety of its iNstroke 4 ...

India's Supernova stent retriever, approved for severe stroke treatment, launches in February 2026, promising affordable ...

University of Calgary researchers published findings from Canada's largest ever acute stroke clinical trial in 2022. It ...

A new study identifies molecular factors that promote small vessel disease - and an active drug that can restore impaired ...

Background Few studies have investigated patient-reported non-motor outcomes after stroke in young adults. We aimed to assess ...

AJMC®: In your experience, what are the most significant long-term clinical effects of a recurrent stroke? RUSSMAN: Recurrent strokes tend to have more severe long-term clinical effects than initial ...

AIIMS New Delhi successfully led India's first clinical trial of the Supernova stent retriever, demonstrating effective and ...

A risk-assessment tool incorporating NT-proBNP and high-sensitivity troponin performs better than clinical scores for predicting stroke among patients with atrial fibrillation (AF) who are taking oral ...